Correlation Between Willamette Valley and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Willamette Valley and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Willamette Valley and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Willamette Valley Vineyards and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Willamette Valley and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Willamette Valley with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Willamette Valley and Regeneron Pharmaceuticals.
Diversification Opportunities for Willamette Valley and Regeneron Pharmaceuticals
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Willamette and Regeneron is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Willamette Valley Vineyards and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Willamette Valley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Willamette Valley Vineyards are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Willamette Valley i.e., Willamette Valley and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Willamette Valley and Regeneron Pharmaceuticals
Assuming the 90 days horizon Willamette Valley Vineyards is expected to generate 1.41 times more return on investment than Regeneron Pharmaceuticals. However, Willamette Valley is 1.41 times more volatile than Regeneron Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.23 per unit of risk. If you would invest 350.00 in Willamette Valley Vineyards on October 10, 2024 and sell it today you would lose (6.00) from holding Willamette Valley Vineyards or give up 1.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Willamette Valley Vineyards vs. Regeneron Pharmaceuticals
Performance |
Timeline |
Willamette Valley |
Regeneron Pharmaceuticals |
Willamette Valley and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Willamette Valley and Regeneron Pharmaceuticals
The main advantage of trading using opposite Willamette Valley and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Willamette Valley position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.Willamette Valley vs. Naked Wines plc | Willamette Valley vs. Pernod Ricard SA | Willamette Valley vs. Brown Forman | Willamette Valley vs. Treasury Wine Estates |
Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |